Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: Characterization of metallo-beta-lactamases, porin OprD and integrons

International Journal of Medical Microbiology

Volumn 304, Issue 3-4, 2014, Pages 405-414

  Rojo Bezares, Beatriz ^a   Estepa, Vanesa ^b   Cebollada, Rocío ^c   de Toro, María ^a,b   Somalo, Sergio ^b   Seral, Cristina ^c,d   Castillo, Francisco Javier ^c,d   Torres, Carmen ^a,b   Sáenz, Yolanda ^a  

^a CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^b UNIVERSITY OF LA RIOJA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Carbapenem resistance; ISPa45; ST175; ST235; ST973

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; METALLO BETA LACTAMASE; NUCLEOTIDE; OUTER MEMBRANE PROTEIN; PORIN; PORIN OPRD; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; OPRD PROTEIN, PSEUDOMONAS AERUGINOSA;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA; CLONE; CONTROLLED STUDY; DILUTION; FEMALE; GENE CASSETTE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HOSPITAL; HOSPITALIZATION; HUMAN; INTEGRON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICRODILUTION; MOLECULAR TYPING; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SPAIN; AGED; ANTIBIOTIC RESISTANCE; CLASSIFICATION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HOSPITALS; HUMANS; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; PORINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPAIN; YOUNG ADULT;

EID: 84899658748     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.01.001     Document Type: Article

References (41)

1. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Second International Supplement. M100-S22 2012, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
2. Cornaglia G., Giamarellou H., Rossolini G.M. Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect. Dis. 2011, 11:381-393.
3. Corvec S., Poirel L., Espaze E., Giraudeau C., Drugeon H., Nordmann P. Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme. J. Hosp. Infect. 2008, 68:73-82.
4. Curran B., Jonas D., Grundmann H., Pitt T., Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 2004, 42:5644-5649.
5. El Amin N., Giske C.G., Jalal S., Keijser B., Kronvall G., Wretlind B. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS 2005, 113:187-196.
6. Ellington M.J., Kistler J., Livermore D.M., Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 2007, 59:321-322.
7. Epp S.F., Köhler T., Plésiat P., Michéa-Hamzehpour M., Frey J., Pechère J.C. C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob. Agents Chemother. 2001, 45:1780-1787.
8. Evans J.C., Segal H. A novel insertion sequence, ISPa26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance. Antimicrob. Agents Chemother. 2007, 51:3776-3777.
9. Farra A., Islam S., Strålfors A., Sörberg M., Wretlind B. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem. Int. J. Antimicrob. Agents 2008, 31:427-433.
10. García-Castillo M., Del Campo R., Morosini M.I., Riera E., Cabot G., Willems R., van Mansfeld R., Oliver A., Cantón R. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J. Clin. Microbiol. 2011, 49:2905-2910.
11. Gutiérrez O., Juan C., Cercenado E., Navarro F., Bouza E., Coll P., Pérez J.L., Oliver A. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 2007, 51:4329-4335.
12. Hammami S., Ghozzi R., Burghoffer B., Arlet G., Redjeb S. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathol. Biol. (Paris) 2009, 57:530-555.
13. Huang H., Hancock R.E. The role of specific surface loop regions in determining the function of the imipenem-specific pore protein OprD of Pseudomonas aeruginosa. J. Bacteriol. 1996, 178:3085-3090.
14. Huang H., Jeanteur D., Pattus F., Hancock R.E. Membrane topology and site-specific mutagenesis of Pseudomonas aeruginosa porin OprD. Mol. Microbiol. 1995, 16:931-941.
15. Juan C., Zamorano L., Mena A., Albertí S., Pérez J.L., Oliver A. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J. Antimicrob. Chemother. 2010, 65:474-478.
16. Lee K., Chong Y., Shin H.B., Kim Y.A., Yong D., Yum J.H. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 2001, 7:88-91.
17. Lister P.D., Wolter D.J., Hanson N.D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 2009, 22:582-610.
18. Nemec A., Krizova L., Maixnerova M., Musilek M. Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic. Res. Microbiol. 2010, 161:234-242.
19. Ocampo-Sosa A.A., Cabot G., Rodríguez C., Roman E., Tubau F., Macia M.D., Moya B., Zamorano L., Suárez C., Peña C., Domínguez M.A., Moncalián G., Oliver A., Martínez-Martínez L. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob. Agents Chemother. 2012, 56:1703-1713. Spanish Network for Research in Infectious Diseases (REIPI).
20. Ochs M.M., Bains M., Hancock R.E. Role of putative loops 2 and 3 in imipenem passage through the specific porin OprD of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2000, 44:1983-1985.
21. Oikonomou O., Panopoulou M., Ikonomidis A. Investigation of carbapenem heteroresistance among different sequence types of Pseudomonas aeruginosa clinical isolates reveals further diversity. J. Med. Microbiol. 2011, 60:1556-1558.
22. Partridge S.R., Tsafnat G., Coiera E., Iredell J.R. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol. Rev. 2009, 33:757-784.
23. Paterson D.L. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis. 2006, 43(Suppl 2):S43-S48.
24. Patzer J.A., Walsh T.R., Weeks J., Dzierzanowska D., Toleman M.A. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006. J. Antimicrob. Chemother. 2009, 63:269-273.
25. Peña C., Suarez C., Gozalo M., Murillas J., Almirante B., Pomar V., Aguilar M., Granados A., Calbo E., Rodríguez-Baño J., Rodríguez F., Tubau F., Martínez-Martínez L., Oliver A., REIPI Spanish Network for Research in Infectious Diseases Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob. Agents Chemother. 2012, 56:1265-1272.
26. Poole K. Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2011, 2:65.
27. Pournaras S., Ikonomidis A., Markogiannakis A., Spanakis N., Maniatis A.N., Tsakris A. Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J. Med. Microbiol. 2007, 56:66-70.
28. Rodríguez-Martínez J.M., Poirel L., Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2009, 53:4783-4788.
29. VIM-2 genes and a new insertion sequence in a Pseudomonas aeruginosa strain isolated from a Spanish hospital. J. Med. Microbiol. 2011, 60:1053-1054.
30. Ruiz-Martínez L., López-Jiménez L., d'Ostuni V., Fusté E., Vinuesa T., Viñas M. A mechanism of carbapenem resistance due to a new insertion element (ISPa133) in Pseudomonas aeruginosa. Int. Microbiol. 2011, 14:51-58.
31. Sáenz Y., Briñas L., Domínguez E., Ruiz J., Zarazaga M., Vila J., Torres C. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal and food origins. Antimicrob. Agents Chemother. 2004, 48:3996-4001.
32. Samuelsen O., Toleman M.A., Sundsfjord A., Rydberg J., Leegaard T.M., Walder M., Lia A., Ranheim T.E., Rajendra Y., Hermansen N.O., Walsh T.R., Giske C.G. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob. Agents Chemother. 2010, 54:346-352.
33. Sardelic S., Bedenic B., Colinon-Dupuich C., Orhanovic S., Bosnjak Z., Plecko V., Cournoyer B., Rossolini G.M. Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia. Antimicrob. Agents Chemother. 2012, 56:2746-2749.
34. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 1995, 33:2233-2239.
35. Tsakris A., Poulou A., Kristo I., Pittaras T., Spanakis N., Pournaras S., Markou F. Large dissemination of VIM-2-metallo-β-lactamase-producing Pseudomonas aeruginosa strains causing health care-associated community-onset infections. J. Clin. Microbiol. 2009, 47:3524-3529.
36. Viedma E., Juan C., Acosta J., Zamorano L., Otero J.R., Sanz F., Chaves F., Oliver A. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob. Agents Chemother. 2009, 53:4930-4933.
37. Viedma E., Juan C., Villa J., Barrado L., Orellana M.A., Sanz F., Otero J.R., Oliver A., Chaves F. VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone. Spain. Emerg. Infect. Dis. 2012, 18:1235-1241.
38. Walsh T.R., Toleman M.A., Poirel L., Nordmann P. Metallo-beta-lactamases: the quiet before the storm?. Clin. Microbiol. Rev. 2005, 18:306-325.
39. Wang J., Zhou J.Y., Qu T.T., Shen P., Wei Z.Q., Yu Y.S., Li L.J. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int. J. Antimicrob. Agents 2010, 35:486-491.
40. Wolter D.J., Hanson N.D., Lister P.D. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol. Lett. 2004, 236:137-143.
41. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 2011, 35:736-755.